Amneal to buy generic pharmaceuticals provider AvKARE for $340m

Amneal to buy generic pharmaceuticals provider AvKARE for $340m

Source: 
Pharmaceutical Business Review
snippet: 

Amneal Pharmaceuticals has signed an agreement to acquire a majority stake in generic pharmaceuticals provider AvKARE for an implied enterprise value of $340m.